logo

For the Inventor, By the Inventor

Haarlem, Netherlands

Cornelis Joseph Maria Melief

This inventor holds 4 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignees: Academisch Ziekenhuis Leiden (h.o.d.n. Lumc), Isa Pharmaceuticals B.v., Academisch Ziekenhuis Bij De Universiteit Van Amsterdam. Active years: 2016-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cornelis Joseph Maria Melief. Retrieved from https://idiyas.com/inventor/cornelis-joseph-maria-melief

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4 

% Patents Active = 75.0

 

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:

goldMedal2 out of 43 
 
Academisch Ziekenhuis Leiden (h.o.d.n. Lumc)
 patents
silverMedal2 out of 7 
 
Isa Pharmaceuticals B.v.
 patents
bronzeMedal1 out of 5 
 
Academisch Ziekenhuis Bij De Universiteit Van Amsterdam
 patents
4. 1 out of 82 
 
Stichting Voor De Technische Wetenschappen
 patents
where one patent can have more than one assignee

Years Active: 2016-2021

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents
1. 10898567 - Synthetic long peptides (SLP) for therapeutic vaccination against Hepatitis B virus infection (2021-01-26),
2. 10376576 - Synthetic long peptides (SLP) for therapeutic vaccination against hepatitis B virus infection (2019-08-13),
3. 9522962 - Peptides, conjugates and method for increasing immunogenicity of a vaccine (2016-12-20),
4. 9393219 - Monophenols and benzenediols sensitization of immune system against haptenized melanoma antigens (2016-07-19),

Title: Cornelis Joseph Maria Melief: Innovator in Therapeutic Vaccination

Introduction

Cornelis Joseph Maria Melief is a notable inventor based in Haarlem, Netherlands. He has made significant contributions to the fields of medicine and immunology, particularly in the development of therapeutic vaccines.

Latest Patents

Melief holds four patents, with his latest inventions focusing on synthetic long peptides (SLP) for therapeutic vaccination against Hepatitis B virus infection. These innovative peptides are designed for the treatment and prevention of Hepatitis B viral infections and related diseases. His work in this area represents a significant advancement in immunological therapies.

Career Highlights

Throughout his career, Melief has been associated with prominent institutions, including Academisch Ziekenhuis Leiden, known as LUMC, and Isa Pharmaceuticals B.V. His research and inventions have played a crucial role in advancing therapeutic options for Hepatitis B.

Collaborations

Melief has collaborated with esteemed colleagues such as Wilhelmus Johannes Theodorus Alexander Krebber and Johan Herman Kessler. These partnerships have further enriched his research and innovation efforts.

Conclusion

Cornelis Joseph Maria Melief's contributions to therapeutic vaccination highlight his role as a leading inventor in the medical field. His work continues to pave the way for advancements in the treatment of viral infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…